Ming Zhou,
Ming, MD, PhD (Dr. Charles T. Ashworth Professor of Pathology, Director of Anatomic Pathology, UT Southwestern Medical Center, Dallax, Texas) Zhou,
George Netto,
George (Professor and Chair of Pathology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama) Netto,
Jonathan I Epstein,
Jonathan I (Reinhard Professor of Urologic Pathology, Director of Surgical Pathology, Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland) Epstein
e.a.
Elsevier Health Sciences
e druk, 2022
9780323653954
Uropathology
Specificaties
Gebonden, blz.
|
Engels
Elsevier Health Sciences |
2022
ISBN13: 9780323653954
Rubricering
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Designed for quick reference and efficient, accurate sign-outs, Uropathology, 2nd Edition, provides superbly illustrated, expert guidance in a time-saving format. This updated volume in the High-Yield Pathology series is highly templated for ease of use, featuring bulleted text, authoritative content, and high-quality images that comprehensively cover both non-neoplastic and neoplastic entities, making it easy to recognize the classic manifestations of urologic diseases and quickly confirm your diagnoses.Provides in-depth, bulleted outlines for each entity covering definition, anatomy, and pathology: histology, immunohistochemistry, and differential diagnosis.Features 1,600 high-quality illustrations that include gross, radiographic imaging, microscopic, immunohistochemical, and special stains, providing a comprehensive visual summary of the typical features of each entity.Includes expanded information on tumor staging expertly provided by Dr. Ming Zhou, primary author of the College of American Pathologists cancer protocols.Reflects recent guidelines and protocols including: Restructured tumor classification and new entitiesNew and modified grading systems for GU cancersNew and modified staging criteria for all GU cancersNew recommendations for reportingNew IHC and molecular markers for diagnosis and prognosis for GU cancersEnhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices
Specificaties
Inhoudsopgave
A. NONNEOPLASTIC DISEASE OF THE PROSTATE<br>1. Anatomy and Histology of the Prostate<br>2. Seminal Vesicle/Ejaculatory Duct<br>3. Cowper Gland<br>4. Benign Prostatic Hyperplasia<br>5. Acute Inflammation of the Prostate<br>6. Chronic Inflammation of the Prostate<br>7. Nonspecific Granulomatous Prostatitis<br>8. Post-Biopsy Granuloma<br>9. Prostatic Xanthoma<br>10. Granulomatous Prostatitis of Infectious Etiology<br>11. Simple Atrophy<br>12. Cystic Atrophy<br>13. Postatrophy Hyperplasia<br>14. Partial Atrophy<br>15. Adenosis<br>16. Sclerosing Adenosis<br>17. Clear Cell Cribriform Hyperplasia<br>18. Hyperplasia of Mesonephric Remnants<br>19. Basal Cell Hyperplasia<br>20. Urothelial Metaplasia<br>21. Squamous Metaplasia<br>22. Mucin Cell Metaplasia<br>23. Neuroendocrine Cells Involving the Prostate<br>24. Verumontanum Mucosal Gland Hyperplasia<br>25. Prostatic Infarct<br>B. NEOPLASTIC DISEASE OF THE PROSTATE<br>26. High-Grade Prostatic Intraepithelial Neoplasia (HGPIN)<br>27. Intraductal Carcinoma of the Prostate<br>28. Prostatic Carcinoma, Usual Variant<br>29. Prostatic Carcinoma, Atrophic Variant<br>30. Prostatic Carcinoma, Foamy Gland Variant<br>31. Prostatic Carcinoma, Pseudohyperplastic Variant<br>32. Prostatic Carcinoma, Mucinous Variant<br>33. Prostatic Carcinoma, Microcystic Variant<br>34. Prostatic Intraepithelial Neoplasia (PIN)-Like Adenocarcinoma<br>35. Sarcomatoid Carcinoma<br>36. Pleomorphic Giant Cell Carcinoma of the Prostate<br>37. Lymphoepithelioma-Like Carcinoma of the Prostate<br>38. Prostate Carcinoma with Squamous Differentiation<br>39. Ductal Adenocarcinoma<br>40. Prostatic Adenocarcinoma with Neuroendocrine Differentiation<br>41. Well-Differentiated Neuroendocrine Tumor<br>42. Small Cell Carcinoma, Prostate<br>43. Prostatic Basal Cell Adenoma<br>44. Basal Cell Carcinoma of the Prostate<br>45. Squamous Neoplasms Including Squamous Cell and Adenosquamous Carcinoma<br>46. Urothelial Carcinoma<br>47. Prostatic Stromal Tumors of Uncertain Malignant Potential<br>48. Prostatic Stromal Sarcoma<br>49. Atypical Glands Suspicious for Prostatic Carcinoma<br>50. High-Grade Prostatic Intraepithelial Neoplasia with Adjacent Atypical Glands<br>51. Radiation-Induced Changes<br>52. Hormonal Ablation-Induced Changes<br>53. Cryoablation Therapy-Induced Changes<br>54. Immunohistochemical Work-Up of Prostate Carcinoma<br>55. Gleason Grading of Prostate Carcinoma<br>56. Prostate Cancer Staging in Radical Prostatectomy<br>57. Genetics and Genomics in Prostate Cancer<br>58. Work-Up of “Vanishing Cancer in Radical Prostatectomy<br>59. Nonprostatic Adenocarcinoma Involving the Prostate<br>C. SEMINAL VESICLES<br>60. Anatomy and Histology of Seminal Vesicles<br>61. Amyloidosis<br>62. Seminal Vesicle Adenocarcinoma<br>63. Mixed Epithelial and Stromal Tumor<br>D. NONNEOPLASTIC DISEASE OF THE URINARY BLADDER<br>64. Anatomy and Histology of the Urinary Bladder<br>65. von Brunn Nests<br>66. Cystitis Cystica et Glandularis<br>67. Squamous Metaplasia<br>68. Intestinal Metaplasia<br>69. Nephrogenic Metaplasia/Adenoma<br>70. Polypoid and Papillary Cystitis<br>71. Follicular Cystitis<br>72. Giant Cell Cystitis<br>73. Interstitial Cystitis/Painful Bladder Syndrome<br>74. Eosinophilic Cystitis<br>75. Infectious Cystitis<br>76. Malakoplakia<br>77. Granulomatous Cystitis After BCG<br>78. Radiation Cystitis<br>79. Chemotherapy-Induced Cystitis<br>80. Endometriosis of the Bladder<br>81. Bladder Endocervicosis<br>82. Bladder Exstrophy<br>83. Urachal Anomaly<br>84. Bladder Diverticulum<br>85. Ectopic Prostate Tissue<br>E. NEOPLASTIC DISEASE OF THE URINARY BLADDER<br>86. Urothelial Proliferation of Uncertain Malignant Potential<br>87. Reactive Urothelial Atypia<br>88. Urothelial Atypia of Unknown Significance<br>89. Urothelial Dysplasia<br>90. Urothelial Carcinoma In Situ<br>91. Urothelial Papilloma<br>92. Inverted Papilloma<br>93. Papillary Urothelial Neoplasm of Low Malignant Potential<br>94. Low-Grade Papillary Urothelial Carcinoma<br>95. High-Grade Papillary Urothelial Carcinoma<br>96. Invasive Urothelial Carcinoma<br>97. Urothelial Carcinoma with Inverted Growth Pattern<br>98. Urothelial Carcinoma with Squamous Differentiation<br>99. Urothelial Carcinoma with Villoglandular Differentiation<br>100. Urothelial Carcinoma, Plasmacytoid Variant<br>101. Urothelial Carcinoma, Nested Variant<br>102. Urothelial Carcinoma, Micropapillary Variant<br>103. Urothelial Carcinoma, Microcystic Variant<br>104. Urothelial Carcinoma, Lymphoepithelioma- Like Carcinoma Variant<br>105. Urothelial Carcinoma, Clear Cell (Glycogen-Rich) Variant<br>106. Lipid-Rich Urothelial Carcinoma<br>107. Urothelial Carcinoma, Giant Cell Variant<br>108. Urothelial Carcinoma with Syncytiotrophoblastic Giant Cells<br>109. Urothelial Carcinoma with Rhabdoid Differentiation<br>110. Urothelial Carcinoma Similar to Giant Cell Tumor of Bone<br>111. Undifferentiated Urothelial Carcinomas<br>112. Small Cell Carcinoma of the Urinary Bladder<br>113. Urothelial Carcinoma with Unusual Stromal Reactions<br>114. Urothelial Carcinoma with Sarcomatoid Differentiation<br>115. Villous Adenoma<br>116. Adenocarcinoma<br>117. Clear Cell Adenocarcinoma<br>118. Urachal Adenocarcinoma<br>119. Squamous Cell Carcinoma<br>120. Paraganglioma<br>121. Staging of Urothelial Carcinoma of the Urinary Bladder and Urethra<br>122. Molecular Genomics of Bladder Cancer<br>123. Secondary Spread of Prostate Carcinoma to the Bladder<br>124. Secondary Adenocarcinoma Involving the Bladder, Other than Prostatic Carcinoma<br>F. NONNEOPLASTIC DISEASE OF THE KIDNEY<br>125. Anatomy of the Kidney<br>126. Renal Dysplasia<br>127. Localized Cystic Disease of the Kidney<br>128. Autosomal Recessive Polycystic Kidney Disease<br>129. Autosomal Dominant Polycystic Kidney Disease<br>130. Medullary Sponge Kidney<br>131. Acquired Cystic Renal Disease<br>132. Simple Cortical Cyst<br>133. Acute Pyelonephritis<br>134. Chronic Nonobstructive Pyelonephritis<br>135. Chronic Obstructive Pyelonephritis<br>136. Xanthogranulomatous Pyelonephritis<br>137. Renal Papillary Necrosis<br>138. Benign Nephrosclerosis<br>139. Malignant Nephrosclerosis<br>140. Acute Kidney Injury (Acute Tubular Necrosis)<br>141. Acute Interstitial Nephritis<br>142. Infectious Interstitial Nephritis<br>G. NEOPLASTIC DISEASE OF THE KIDNEY<br>143. Papillary Adenoma<br>144. Renal Oncocytoma<br>145. Clear Cell Renal Cell Carcinoma<br>146. Multilocular Cystic Renal Neoplasm of Low Malignant Potential<br>147. Papillary Renal Cell Carcinoma<br>148. Chromophobe Renal Cell Carcinoma<br>149. Fumarate Hydratase-Deficient Renal Cell Carcinoma, Including Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome<br>150. Collecting Duct Carcinoma<br>151. Renal Medullary Carcinoma<br>152. MIT Family Translocation Renal Cell Carcinoma<br>153. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma<br>154. Mucinous Tubular and Spindle Cell Carcinoma<br>155. Tubulocystic Carcinoma<br>156. Acquired Cystic Kidney Disease-Associated Renal Cell Carcinoma<br>157. Thyroid-Like Follicular Renal Cell Carcinoma<br>158. Clear Cell Papillary Renal Cell Carcinoma<br>159. Renal Cell Carcinoma with Fibromyomatous Stroma<br>160. Eosinophilic Solid Cystic Renal Cell Carcinoma<br>161. Renal Cell Carcinoma with Somatic Mutations in TSC/mTORC1 Genes<br>162. Renal Cell Carcinoma with Sarcomatoid Differentiation<br>163. Renal Cell Carcinoma, Unclassified Type<br>164. Grading System for Renal Cell Carcinoma<br>165. Staging of Renal Cell Carcinoma<br>166. Renal Cell Carcinoma in von Hippel-Lindau Disease<br>167. Renal Cell Neoplasms in Birt-Hogg-Dubé (BHD) Syndrome<br>168. Renal Tumors in Tuberous Sclerosis Complex (TSC)<br>169. Metanephric Adenoma<br>170. Metanephric Stromal Tumor<br>171. Wilms Tumor<br>172. Nephrogenic Rests and Nephroblastomatosis<br>173. Congenital Mesoblastic Nephroma (CMN)<br>174. Rhabdoid Tumor of the Kidney<br>175. Clear Cell Sarcoma of the Kidney<br>176. Ossifying Renal Tumor of Infancy<br>177. Renal Angiomyolipoma<br>178. Epithelioid Angiomyolipoma<br>179. Juxtaglomerular Cell Tumor<br>180. Renal Medullary Fibroma (Renomedullary Interstitial Cell Tumor)<br>181. Mixed Epithelial and Stromal Tumor Family<br>182. Primary Renal Synovial Sarcoma<br>183. Renal Carcinoid Tumor<br>H. RENAL PELVIS AND URETER<br>184. Ureteropelvic Junction Obstruction<br>185. Idiopathic Retroperitoneal Fibrosis, Including IgG4-Related Disease<br>186. Fibroepithelial Polyp of the Ureter and Renal Pelvis<br>187. Ureteral Urothelial Carcinoma and Staging<br>188. Staging for Pelvic Urothelial Carcinoma<br>I. NONNEOPLASTIC DISEASE OF THE TESTIS<br>189. Testis: Anatomy and Histology<br>190. Cryptorchidism<br>191. Testiculosplenic Fusion<br>192. Adrenal Cortical Rests<br>193. Spermatic Cord Torsion and Testicular Infarction<br>194. Testicular Microlithiasis<br>195. Vasculitis<br>196. Male Infertility Workup<br>197. Maturation Arrest<br>198. Hypospermatogenesis<br>199. Germ Cell Aplasia, Sertoli Cell-only Syndrome<br>200. Excurrent Duct Obstruction<br>201. Pre-pubertal Gonadotropin Deficiency<br>202. Postpubertal Gonadotrophin Deficiency<br>203. Viral Orchitis<br>204. Granulomatous Orchiepididymitis<br>205. Nonspecific Granulomatous Orchitis<br>206. Androgen Insensitivity Syndrome<br>207. Klinefelter Syndrome<br>208. Testicular Tumor of the Adrenogenital Syndrome<br>209. Embryonic Testicular Regression (Vanishing Testis Syndrome)<br>210. Gonadal Dysgenesis<br>J. NEOPLASTIC DISEASE OF THE TESTIS<br>211. Germ Cell Neoplasia In Situ<br>212. Specific Forms of Intratubular Germ Cell Neoplasia<br>213. Seminoma<br>214. Embryonal Carcinoma<br>215. Postpubertal-Type Yolk Sac Tumor<br>216. Postpubertal-Type Teratoma<br>217. Mixed Germ Cell Tumor<br>218. Teratoma with Somatic-Type Malignancies<br>219. Choriocarcinoma<br>220. Non-Choriocarcinomatous Trophoblastic Tumors<br>221. Regressed Germ Cell Tumors<br>222. Spermatocytic Tumor<br>223. Prepubertal-Type Teratoma, Testicular Carcinoid Tumor<br>224. Teratoma, Prepubertal-Type, Dermoid Cyst<br>225. Prepubertal Teratoma, Epidermoid Cyst<br>226. Yolk Sac Tumor, Prepubertal Type<br>227. Leydig Cell Tumor<br>228. Sertoli Cell Tumor<br>229. Sclerosing Sertoli Cell Tumor<br>230. Large Cell Calcifying Sertoli Cell Tumor<br>231. Adult Granulosa Cell Tumor<br>232. Juvenile Granulosa Cell Tumor<br>233. Fibrothecoma<br>234. Stromal Tumor of the Testis, Mixed and Unclassified Type<br>235. Myoid Gonadal Stromal Tumor<br>236. Gonadoblastoma<br>237. Testicular Lymphoma<br>238. Ovarian Epithelial-Type Testicular Tumors<br>239. Tumors of the Rete Testis<br>240. Testicular Cancer Staging<br>K. SPERMATIC CORD AND TESTICULAR ADNEXA<br>241. Appendix Testis<br>242. Appendix Epididymis<br>243. Glandular Inclusions in Inguinal Herniorrhaphy Specimens<br>244. Hydrocele<br>245. Spermatocele<br>246. Vasitis Nodosa<br>247. Sperm Granuloma<br>248. Adenomatoid Tumor<br>249. Fibrous Pseudotumor<br>250. Paratesticular Idiopathic Smooth Muscle Hyperplasia<br>251. Papillary Cystadenoma of the Epididymis<br>252. Paratesticular Lipoma<br>253. Paratesticular Liposarcoma<br>254. Paratesticular Rhabdomyosarcoma<br>255. Leiomyoma of the Spermatic Cord and Testicular Adnexa<br>256. Paratesticular Leiomyosarcoma<br>257. Aggressive Angiomyxoma of the Male Genital Region<br>258. Cellular Angiofibroma<br>259. Malignant Mesothelioma, Paratesticular<br>260. Epithelial Tumors of the Rete Testis<br>L. DISEASE OF THE PENIS, URETHRA, AND SCROTUM<br>261. Fibroepithelial Polyp of the Urethra<br>262. Urethral Caruncle<br>263. Urethral Diverticulum<br>264. Urethral Stricture<br>265. Polypoid Urethritis<br>266. Condyloma Acuminatum<br>267. Prostatic-Type Urethral Polyp<br>268. Urethral Urothelial Carcinoma Associated with Bladder Urothelial Carcinoma<br>269. Primary Urethral Carcinoma<br>270. Urethral Adenocarcinoma<br>271. Clear Cell Adenocarcinoma of the Urethra<br>272. Zoon Balanitis<br>273. Lichen Sclerosus et Atrophicus (Balanitis Xerotica Obliterans)<br>274. Pseudoepitheliomatous Keratotic Micaceous Balanitis<br>275. Peyronie Disease<br>276. Squamous Hyperplasia of the Penis<br>277. Penile Intraepithelial Neoplasia (PeIN)<br>278. Differentiated Penile Intraepithelial Neoplasia<br>279. Squamous Cell Carcinoma of the Penis, Usual Type<br>280. Basaloid Squamous Cell Carcinoma<br>281. Squamous Cell Carcinoma, Papillary- Basaloid<br>282. Penile Warty (Condylomatous) Carcinoma<br>283. Squamous Cell Carcinoma, Warty-Basaloid<br>284. Clear Cell Squamous Cell Carcinoma<br>285. Lymphoepithelioma-Like Carcinoma<br>286. Squamous Cell Carcinoma, Verrucous<br>287. Squamous Cell Carcinoma, Papillary<br>288. Squamous Cell Carcinoma, Pseudohyperplastic Variant<br>289. Squamous Cell Carcinoma, Pseudoglandular<br>290. Squamous Cell Carcinoma, Cuniculatum<br>291. Sarcomatoid (Spindle Cell) Squamous Cell Carcinoma of the Penis<br>292. Adenosquamous Carcinoma of the Penis<br>293. Mixed Squamous Cell Carcinoma of the Penis<br>294. Penile Basal Cell Carcinoma<br>295. Extramammary Paget Disease of the Penis and Scrotum<br>296. Merkel Cell Carcinoma of the Genitourinary Tract<br>297. Sclerosing Lipogranuloma<br>298. Idiopathic Scrotal Calcinosis<br>299. Genital Melanosis and Lentiginosis<br>300. Mucosal Melanoma of the Genitourinary System<br>301. Staging for Penile Squamous Cell Carcinoma<br>302. Staging for Urethral Carcinoma<br>M. SOFT TISSUE TUMORS<br>303. Inflammatory Myofibroblastic Tumor of the Bladder<br>304. Leiomyoma of the Bladder<br>305. Leiomyosarcoma of the Bladder<br>306. Solitary Fibrous Tumor<br>307. Gastrointestinal Stromal Tumor of the Genitourinary Tract<br>308. Lymphomas of the Genitourinary Organs